Healthcare
March 29, 2018 / 1:34 PM / a year ago

BRIEF-Jilin Province Huinan Changlong Bio-Pharmacy Co Says FY Revenue RMB645.3 Mln

1 Min Read

March 29 (Reuters) - Jilin Province Huinan Changlong Bio-Pharmacy Co Ltd:

* FY REVENUE RMB645.3 MILLION VERSUS RMB654.1 MILLION

* FY ‍PROFIT ATTRIBUTABLE RMB144.4 MILLION VERSUS RMB142.7 MILLION Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below